COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patternsWHO 아프리카 지역 47개국의 COVID-19: 과거 동향 및 미래 패턴의 모델링 분석Article Published on 2022-08-012022-09-11 Journal: The Lancet. Global health [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI affected African Analysis approach build Comorbidities country Coverage COVID-19 COVID-19 infection COVID-19 infections dead death deaths estimate Fourier series Fourier sery generate hospitalisations Immunity immunogenicity Infection infections information introduced Markov decision process New pandemic public health Public health interventions reduce reported robust SARS-CoV-2 immunity SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 testing sequenced severity Statistics Surveillance susceptible the WHO Transmissibility Transmission dynamics vaccination variant variants variants of concern WHO [DOI] 10.1016/S2214-109X(22)00233-9 PMC 바로가기 [Article Type] Article
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational studyObservational Study Published on 2022-08-012022-10-04 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 임상, [키워드] age analysed approach association Characteristics clinical Clinical outcome clinical trials Cluster cluster analysis Clustering Clusters Cognitive impairment Cohort comparison Concentration COVID COVID-19 described discharge discharged domains effective Factor female full recovery Health hospital Hospital admission hospital discharge hospitalisation identify IL-6 improvement Inflammation Inflammatory inflammatory mediator Innovation Intervention Invasive mechanical ventilation ISRCTN registry less logistic regression modelling longitudinal cohort study median men mental health Mild moderate obesity Odds ratio organ function outcome measure outcome measures participant Participants Patient pharmacological PHOSP-COVID physical plasma Post-hospitalisation COVID-19 study potential therapeutic target profile proportion prospective observational study Protein Quality of life recruitment Registered reported retrospective severity Sex stratified tissue damage treatable utility was done was increased was performed was reduced were assessed WHO with COVID-19 women [DOI] 10.1016/S2213-2600(22)00127-8 PMC 바로가기 [Article Type] Observational Study
Adverse events following COVID-19 vaccination: A systematic review and meta-analysisResearch article Published on 2022-08-012022-10-05 Journal: International immunopharmacology [Category] 비임상, 임상, [키워드] 95% CI Adverse adverse event adverse events Adverse reaction approved benefit calculated clinical trial control group COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines database DNA DNA vaccine Efficacy Efficacy and safety event greater immunization Inactivated vaccine ISI Local Meta-analysis mRNA mRNA vaccine Occurrence protein subunit vaccine raised Result risk Safety SARS-CoV-2 searched systematic review systemic adverse reaction systemic and local vaccination Vaccine Vaccines WHO [DOI] 10.1016/j.intimp.2022.108906 [Article Type] Research article
Nanoparticles in clinical trials of COVID-19: An updateReview article Published on 2022-08-012022-10-05 Journal: International journal of surgery (London, England) [Category] 변종, 임상, 치료제, [키워드] approved benefit Bioavailability clinical trial clinical trials COVID-19 COVID-19 disease COVID-19 vaccination drug delivery drugs effective effective vaccine Efficacy Efficiency effort example exhibit globe highlighting Immunity Immunotherapy inaccessible increasingly indication Infectious disease investigated long-lasting medication Medicine Medicines nanoparticle Nanoparticles outbreak outcomes pandemic provide reducing researcher Safe SARS-CoV-2 antigen Strategy therapeutic therapy Toxicity Treatment Vaccine Vaccines WHO World Health Organization [DOI] 10.1016/j.ijsu.2022.106818 [Article Type] Review article
Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq이라크에서 SARS-CoV-2의 델타 변이체와 비교하여 새로 출현한 오미크론 변이체의 스파이크 단백질의 분자 및 컴퓨터 분석Article Published on 2022-08-012022-09-11 Journal: Molecular biology reports [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 acute respiratory syndrome coronavirus Affect amino acids angiotensin angiotensin converting enzyme binding affinity bioinformatics computational analysis computational tool computational tools concerning contagious contributing to COVID-19 Delta delta variant Delta variants disorder Docking studies docking study engage enzyme greater Health higher affinity human ACE2 human angiotensin converting enzyme 2 hydrophobic amino acid identify Interaction Iraq less molecular molecular docking omicron Omicron variant Omicron variants pathogenicity PCR Phylogenetic analysis physical physical and chemical properties predicted qPCR RBD RBD region Receptor binding domain respiratory SARS-CoV-2 SARS-CoV-2 variants Sequencing severe acute respiratory syndrome Coronavirus Spike protein stability the spike protein Transmissibility Transmission Vaccine variant variant of SARS-CoV-2 variants variants of concern virus were used WHO [DOI] 10.1007/s11033-022-07545-4 PMC 바로가기 [Article Type] Article
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesArticle Published on 2022-08-012022-11-15 Journal: Journal of Clinical Immunology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] affected analyzed auto-antibody autoantibodies benefit Biomarker circulating Clinical outcome clinical parameter clinically Cohort COVID-19 COVID-19 patient Critical Critically ill critically ill patients defined detectable disease Effect ELISA evaluated FIVE hospital Hospital admission hospitalized COVID-19 patient identification IFN-α interferon male Neutralization assay Neutralizing Neutralizing activity Oxygen requirement Patient post-symptom onset Prevalence probability of survival Rapid reduced SARS-CoV-2 SARS-CoV-2 antibody sera severe COVID-19 specificity subsequent survival Therapeutic plasma exchange Therapies TPE Type type I interferon undetectable uninfected control WHO [DOI] 10.1007/s10875-022-01252-2 PMC 바로가기
Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021Article Published on 2022-08-012022-11-16 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] age analysed Antigen approved Characteristics clinical evaluation common Department Diagnosis diagnostic Emergency European group highest incidence Infection Infectious disease list lowest National national study no symptoms PCR test PCR-negative PCR-positive rapid antigen test Rapid diagnostic test recorded Registered reported Result role Saliva SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 delta sensitivity Sensitivity and specificity subgroup Symptom Symptoms System union United Kingdom vaccination variant Viral load was recorded WHO World Health Organization [DOI] 10.2807/1560-7917.ES.2022.27.33.2200070 PMC 바로가기
Performance and application evaluation of SARS-CoV-2 antigen assaySARS-CoV-2 항원 분석의 성능 및 응용 평가Review Published on 2022-08-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Accessibility accumulated acute respiratory syndrome acute respiratory syndrome coronavirus addition alleviate Antigen antigen detection approved Asymptomatic can not Clinical data coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis COVID-19 vaccines diagnoses Diagnosis False positive False positives gold gold standard hospitals increase in Interpretation Laboratory laboratory diagnosis mutant mutant strain Mutant strains Negative predictive value nucleic acid Nucleic acid detection offer performance positive result Practitioner Predictive value Prevalence Probability promote reagent SARS-CoV-2 SARS-CoV-2 antigen SARS-COV-2 infection SARS-CoV-2 nucleic acid sensitivity Sensitivity and specificity severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specificity speed the SARS-CoV-2 the WHO trade-off WHO [DOI] 10.1002/jmv.27798 PMC 바로가기 [Article Type] Review
Methylene blue applied to N95 respirators and medical masks for SARS-CoV-2 decontamination: What is the likelihood of inhaling methylene blue?SARS-CoV-2 오염 제거를 위해 N95 호흡기 및 의료용 마스크에 적용된 메틸렌 블루: 메틸렌 블루를 흡입할 가능성은 무엇입니까?Article Published on 2022-08-012022-09-11 Journal: American journal of infection control [Category] SARS, 치료기술, [키워드] absorbance applied aqueous solution cloth mask cloth masks coronavirus COVID-19 detectable develop Effluent gas effort equipment equivalent Evidence global health global pandemic Health care Health care worker health care workers Health Organization likelihood Mask Medical mask medical masks Methylene Methylene blue N95 respirator N95 respirators oxygen Personal protective equipment Personal protective equipment (PPE) photodynamic therapy PPE Protective resource Respirator reuse Safe SARS-CoV-2 singlet oxygen Singlet oxygen. Spectroscopy the WHO ultraviolet were used WHO World Health Organization [DOI] 10.1016/j.ajic.2022.03.003 PMC 바로가기 [Article Type] Article
Variations of COVID-19 mortality are affected by economic disparities across countriesCOVID-19 사망률의 변화는 국가 간 경제적 격차에 영향을 받습니다.Article Published on 2022-08-012022-09-11 Journal: The Science of the total environment [Category] SARS, 변종, [키워드] Affect affected average mortality Case fatality rate case fatality rates CFRs Clinical outcome clinical outcomes country COVID-19 COVID-19 case COVID-19 disease COVID-19 mitigation COVID-19 mortality cross-sectional cross-sectional study cumulative Dashboard death decreasing dominant Economy Efficiency exhibited Factor Factors First wave health system income Income levels increase in increased mortality management maximum medical resource Mitigation Mortality mortality rate mortality rates much lower outcome patients performed Policy population density populations Prevent reduction Region reported reversed second wave situation Stage the disease time lag Transmission Turning Turning points unit variant Wave Waves WHO Worldometer [DOI] 10.1016/j.scitotenv.2022.154770 PMC 바로가기 [Article Type] Article